Data compiled by Redley Lamar · ChainSifter Intelligence
2Suppliers
2Customers
3Debt Items
20Related Chains
Source-Backed Evidence Depth
Ovid Therapeutics Inc. (OVID) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
8Total relationships
2Distinct source URLs
4High confidence
0.810Average confidence
2026-10-28Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Reciprocal relationship from LGND graph: Reciprocal relationship from OVID graph: Reciprocal relationship from LGND graph: tia”) in September 2023) in 2017, Ovid Therapeutics Inc. (“Ovid”) in October…
Reciprocal relationship from LGNZZ graph: Reciprocal relationship from OVID graph: Reciprocal relationship from LGNZZ graph: Reciprocal relationship from OVID graph: Reciprocal relationship from LGNZ…
ndensed consolidated balance sheets. ROU assets represent the right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arisi…
Ovid Therapeutics Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
OVID-DEBT-11627
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2021-12-31.
OVID-DEBT-59802
Warrants outstanding: 1.09
90%
xbrl warrant detail from xbrl 2026-03-31.
OVID-DEBT
Debt stack $13.1M
90%
Market cache reports total debt of $13.1M.
Ovid Therapeutics Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Ovid Therapeutics Inc..
Ovid Therapeutics Inc. Ownership
Holder
Name
Confidence
Evidence
OVID-OWNER-JANUS-HENDERSON-GROUP-PLC
JANUS HENDERSON GROUP PLC
90%
13F overlay lists JANUS HENDERSON GROUP PLC as top holder; 104 tracked holders.
Ovid Therapeutics Inc. Extended Supply Chain Network